Dr Reddys Laboratories Ltd spurts 1.99%, gains for third straight session
NSE is in focus.
21 Sept 2026 · Business Standard Mkts
Dr Reddys Laboratories Ltd is quoting at Rs 1208.6, up 1.99% on the day as on 12:49 IST on the NSE. The stock is down 7.13% in last one year as compared to a 7.1% fall in NIFTY and a 20.91% fall in the Nifty Pharma index.
The analysis
NSE reported Rs 1208.6, with movement of 7.1%, 1.99% and 7.13% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Why it matters
- With NSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Market wrap: ITC, BSE, HCL Tech, Asian Paints top gainers and losers on Nifty and Sensex on Monday
Stock Market Today LIVE: Sensex Rises 500 Points, Nifty 50 Holds 22,700; India VIX Leaps 7%; Trent Rallies 12%
Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath
Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review
Buy, Sell Or Hold: HDFC Bank, Sun Pharma, Rallis India, Trent | Ask Profit